Obtaining new feeder cell lines expressing membrane-bound forms of IL-12 and IL-18 to improve the anti-tumor properties of natural killer cells

Authors

  • Nastassia S. Mukhametshyna Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus
  • Alexander A. Migas Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus
  • Hanna V. Klych Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus
  • Yauheni A. Lasiukov Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus
  • Tatsiana V. Shman Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus

Keywords:

natural killer cells, interleukins, feeder cell lines, acute leukemia, immunotherapy
Supporting Agencies
The work was funded by the state program «Science-intensive technologies and equipment» for 2021–2025 (subprogram 1 «Innovative biotechnologies», task 5).

Abstract

Numerous clinical studies are currently underway on the use of natural killer cells in the treatment of cancer and solid tumors. However, such immunotherapy may be limited by the short persistence of natural killer cells in the host body and the ability of tumor cells to avoid recognition by natural killer cells. Solving these problems by modifying the initial properties of natural killer cells can significantly increase the effectiveness of antitumor therapy. One of the methods of modification is the use of new feeder cell lines expressing various combinations of membrane-bound cytokines (IL-12, IL-15, IL-18, IL-21) to obtain natural killer cells with a specific phenotype (memory-like). In the course of the work done, two new feeder cell lines based on K-562 cells with ectopic expression of a combination of interleukins IL-15, IL-12, IL-18 and IL-21, IL-12, IL-18 were obtained for the expansion of natural killer cells with enhanced antitumor activity.

Author Biographies

  • Nastassia S. Mukhametshyna, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus

    junior researcher at the laboratory of immunological research

  • Alexander A. Migas, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus

    head of the laboratory of immunological research

  • Hanna V. Klych, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus

    junior researcher at the laboratory of genetic biotechnologies

  • Yauheni A. Lasiukov, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus

    junior researcher at the laboratory of immunological research

  • Tatsiana V. Shman, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, 43 Frunzienskaja Street, Baraŭliany 223053, Minsk District, Belarus

    PhD (biology); leading researcher at the laboratory of immunological research

References

  1. Abel AM, Yang C, Thakar MS, Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Frontiers in Immunology. 2018;9:1869. DOI: 10.3389/fimmu.2018.01869.
  2. Becker PSA, Suck G, Nowakowska P, Ullrich E, Seifried E, Bader P, et al. Selection and expansion of natural killer cells for NK cell-based immunotherapy. Cancer Immunology, Immunotherapy. 2016;65(4):477–484. DOI: 10.1007/s00262-016-1792-y.
  3. Vashkevich EP, Migas AA, Meleshko AN, Matveyenka MA, Strushkevich NV, Shman TV. Human natural killer cells expansion and activation ex vivo in the presence of transgenic feeder cell lines. Tsitologiya. 2020;62(4):258–265. Russian. DOI: 10.31857/S0041377120040070.
  4. Pahl JHW, Cerwenka A, Ni J. Memory-like NK cells: remembering a previous activation by cytokines and NK cell receptors. Frontiers in Immunology. 2018;9:2796. DOI: 10.3389/fimmu.2018.02796.
  5. Somanchi SS, Senyukov VV, Denman CJ, Lee DA. Expansion, purification, and functional assessment of human peripheral blood NK cells. Journal of Visualized Experiments. 2011;48:2540. DOI: 10.3791/2540.
  6. Shevtsova A. Evaluation of the effect of cytokines: IL-12, IL-18 and their combinations on the expansion, activation and functional activity of NK-cells. In: 14th Bialystok International Medical Congress for Young Scientists; 2019 May 17–18; Bialystok, Poland. Bialystok: [s. n.]; 2019. p. 79.
  7. Shevtsova AS. [Changing the properties of natural killer cells using genetically modified feeder cell lines for the purposes of antitumor immunotherapy]. In: Aktual’nye problemy i perspektivy razvitiya detskoi gematologii-onkologii v Rossiiskoi Federatsii. Sbornik materialov I Ob’edinennogo kongressa NODGO i RODO; 23–25 noyabrya 2020 g.; Moskva, Rossiya [Actual problems and prospects for the development of pediatric hematology and oncology in the Russian Federation. Collection of materials of the 1st Joint congress of NODGO and RODO; 2020 November 23–25; Moscow, Russia]. Moscow: National Society of Pediatric Hematologists and Oncologists; 2020. p. 110. Russian.
  8. Mukhametshina AS, Migas AA, Matveenko MA, Shman TV. [Creation and use of genetically engineered feeder cell lines for the expansion of natural killer cells with increased production of IFN-γ]. In: Goncharov AE, Skorobogatova AS, Poleshko AG, Martynova MA, Pinchuk SV, Bushmakina IM, et al., editors. Sovremennye problemy kletochnoi inzhenerii, immunologii i allergologii. Tezisy dokladov Mezhdunarodnoi nauchnoi konferentsii; 20–21 maya 2021 g.; Minsk, Belarus’ [Modern problems of cell engineering, immunology and allergology. Abstracts of the International scientific conference; 2021 May 20–21; Minsk, Belarus]. Minsk: [s. n.]; 2021. p. 36. Russian.
  9. Mukhametshyna N, Lasiukov Ya, Shman T. Harnessing genetically engineered feeder cell line for ex vivo expansion of human natural killer cells with increased production of IFN-γ. In: Juozaitytė E, editor. 7th Kaunas/Lithuania International Hematology/Oncology Colloquium; 2022 May 26; Kaunas, Lithuania. [S. l.]: [s. n.]; 2022. p. 10–11.

Downloads

Additional Files

Published

2023-02-28

Issue

No. 1 (2023): Experimental Biology and Biotechnology

Section

Biotechnology and Microbiology

License

The authors who are published in this journal agree to the following:

  1. The authors retain copyright on the work and provide the journal with the right of first publication of the work on condition of license Creative Commons Attribution-NonCommercial. 4.0 International (CC BY-NC 4.0).
  2. The authors retain the right to enter into certain contractual agreements relating to the non-exclusive distribution of the published version of the work (e.g. post it on the institutional repository, publication in the book), with the reference to its original publication in this journal.
  3. The authors have the right to post their work on the Internet (e.g. on the institutional store or personal website) prior to and during the review process, conducted by the journal, as this may lead to a productive discussion and a large number of references to this work. (See The Effect of Open Access.)

How to Cite

Mukhametshyna, N. S. ., Migas, A. A. ., Klych, H. V. ., Lasiukov, Y. A. ., & Shman, T. V. . (2023). Obtaining new feeder cell lines expressing membrane-bound forms of IL-12 and IL-18 to improve the anti-tumor properties of natural killer cells. Experimental Biology and Biotechnology, 1, 33-40. https://doi.org/10.33581/2957-5060-2023-1-33-40